Rare diseases
Executive Summary
The Rare Disease Act (HR 4013) reauthorizing the NIH Office of Rare Diseases and providing for Rare Diseases Centers of Excellence is signed into law by President Bush Nov. 6. Rare Diseases Orphan Products Development Act (HR 4014) is signed the same day. Law reauthorizes $25 mil. in grants each year through FY 2006 to help FDA fund research on orphan drug products...